Nonetheless, for the endometrial and ovarian cancer patients, we were able to demonstrate 3 simultaneous findings pointing to the biologically important phenomenon of enhanced transmigration: increased monocyte count, increased expression of monocyte CD54 Ag, and its significant correlation with the expression of another molecule participating in the transmigration, CD62 L. Here, ICAM1 is linked to ovarian cancer.